Loading...
XJPX4925
Market cap39mUSD
Jan 16, Last price  
1,625.00JPY
1D
0.00%
1Q
-15.36%
Jan 2017
-58.23%
Name

Haba Laboratories Inc

Chart & Performance

D1W1MN
XJPX:4925 chart
P/E
P/S
0.50
EPS
Div Yield, %
2.46%
Shrs. gr., 5y
-0.79%
Rev. gr., 5y
-8.54%
Revenues
12.32b
+2.38%
11,042,840,00011,182,798,00011,318,015,00011,809,979,00013,578,544,00013,233,767,00013,786,971,00013,181,178,00014,811,078,00016,135,567,00017,885,688,00019,253,557,00018,369,640,00014,307,709,00012,908,861,00012,038,052,00012,324,210,000
Net income
-2.12b
L+199.30%
299,831,000393,361,000266,498,00022,127,000537,865,00010,052,000916,354,00044,834,000982,403,0001,213,611,0001,597,847,0002,088,478,0001,313,475,000216,419,000-269,030,000-707,865,000-2,118,627,000
CFO
-588m
L
272,200,000975,563,000362,591,000411,546,000682,490,0001,521,915,0001,540,149,000-178,754,0001,907,071,0001,495,317,0002,670,956,0001,921,810,000675,509,000534,710,0001,714,447,00055,956,000-587,921,000
Dividend
Mar 28, 20250 JPY/sh

Profile

HABA Laboratories,Inc. manufactures and sells skin care, and hair and body care products in Japan and internationally. Its skin care products include cleansers/face washes, toners, special care products, and squalane oils; and hair and body care products comprise shampoos, conditioners, soaps, and hair and hand treatment products. The company sells its products through mail order, shops, drug/variety stores, and internet. It has approximately 70 HABA shops located in department stores, shopping malls, etc. HABA Laboratories,Inc. was founded in 1983 and is headquartered in Tokyo, Japan.
IPO date
Jun 11, 2003
Employees
654
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑032015‑03
Income
Revenues
12,324,210
2.38%
12,038,052
-6.75%
12,908,861
-9.78%
Cost of revenue
12,511,871
12,296,220
12,763,605
Unusual Expense (Income)
NOPBT
(187,661)
(258,168)
145,256
NOPBT Margin
1.13%
Operating Taxes
275,315
159,201
2,075
Tax Rate
1.43%
NOPAT
(462,976)
(417,369)
143,181
Net income
(2,118,627)
199.30%
(707,865)
163.12%
(269,030)
-224.31%
Dividends
(151,171)
(151,282)
(151,122)
Dividend yield
1.92%
1.72%
1.85%
Proceeds from repurchase of equity
(400,064)
BB yield
4.90%
Debt
Debt current
1,354,720
1,001,091
1,085,040
Long-term debt
1,000,360
1,031,752
1,472,843
Deferred revenue
(76,705)
(75,406)
Other long-term liabilities
59,118
51,412
43,164
Net debt
(1,615,979)
(3,062,483)
(3,433,026)
Cash flow
Cash from operating activities
(587,921)
55,956
1,714,447
CAPEX
(154,000)
(288,650)
(187,505)
Cash from investing activities
(441,788)
(214,402)
(216,492)
Cash from financing activities
171,065
(676,322)
(1,512,977)
FCF
65,612
31,009
1,720,341
Balance
Cash
3,959,197
4,817,842
5,651,289
Long term investments
11,862
277,484
339,620
Excess cash
3,354,848
4,493,423
5,345,466
Stockholders' equity
8,830,470
11,097,018
11,961,041
Invested Capital
7,566,448
8,098,500
8,694,497
ROIC
1.49%
ROCE
1.03%
EV
Common stock shares outstanding
3,782
3,782
3,782
Price
2,077.00
-10.86%
2,330.00
7.82%
2,161.00
-52.56%
Market cap
7,854,215
-10.86%
8,810,939
7.82%
8,171,917
-52.56%
EV
6,238,236
5,748,456
4,738,891
EBITDA
331,609
301,488
853,334
EV/EBITDA
18.81
19.07
5.55
Interest
9,731
6,055
7,170
Interest/NOPBT
4.94%